$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000143774921005031 Filed on March 04, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2018
Revenue	$37.70M	$4.264M	$477.1M
YoY Change	784.15%	171.77%	3788.3%
Cost Of Revenue	$4.300M	$130.0K	$95.27M
YoY Change	3207.69%	26.21%
Gross Profit	$33.40M	$4.134M	$381.8M
YoY Change	707.93%	181.99%	3011.79%
Gross Profit Margin	88.59%	96.95%	80.03%
Selling, General & Admin	$3.400M	$3.497M	$12.88M
YoY Change	-2.77%	-8.65%	4.69%
% of Gross Profit	10.18%	84.59%	3.37%
Research & Development	$3.000M	$3.924M	$13.02M
YoY Change	-23.55%	31.99%	-21.96%
% of Gross Profit	8.98%	94.92%	3.41%
Depreciation & Amortization	$130.0K	$130.0K	$69.63K
YoY Change	0.0%	550.0%	-47.33%
% of Gross Profit	0.39%	3.14%	0.02%
Operating Expenses	$6.600M	$7.421M	$122.0M
YoY Change	-11.06%	9.12%	291.91%
Operating Profit	$26.80M	-$3.470M	$355.1M
YoY Change	-872.33%	-37.38%	-1983.9%
Interest Expense	-$600.0K	-$3.600M	$15.48M
YoY Change	-83.33%	-35.71%	4.88%
% of Operating Profit	-2.24%		4.36%
Other Income/Expense, Net	$100.0K	$600.0K	$78.94M
YoY Change	-83.33%	-99.24%	470122.69%
Pretax Income	$26.30M	-$6.500M	$411.6M
YoY Change	-504.62%	-109.62%	-1173.96%
Income Tax	$6.100M	-$2.000M	-$10.17M
% Of Pretax Income	23.19%		-2.47%
Net Earnings	$20.20M	-$4.503M	$421.8M
YoY Change	-548.59%	-108.59%	-1264.07%
Net Earnings / Revenue	53.58%	-105.61%	88.42%
Basic Earnings Per Share		-$0.06	$5.28
Diluted Earnings Per Share	$260.3K	-$0.06	$5.18
COMMON SHARES
Basic Shares Outstanding	77.40M	80.94M shares	79.92M
Diluted Shares Outstanding			82.71M

Balance Sheet

Concept	2020 Q4	2019 Q4	2018
SHORT-TERM ASSETS
Cash & Short-Term Investments	$117.9M	$65.20M	$100.7M
YoY Change	80.83%	-35.25%	406.03%
Cash & Equivalents	$117.9M	$65.25M	$100.7M
Short-Term Investments
Other Short-Term Assets	$2.100M	$100.9M	$15.80M
YoY Change	-97.92%	538.61%	24.41%
Inventory	$20.27M	$9.653M	$2.900M
Prepaid Expenses
Receivables	$3.340M	$4.168M	$2.000M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$143.6M	$180.0M	$121.3M
YoY Change	-20.24%	48.44%	224.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.104M	$2.618M	$200.0K
YoY Change	-19.64%	1428.72%	100.0%
Goodwill	$898.3K	$898.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$676.9K	$856.8K	$81.10M
YoY Change	-20.99%	-19.09%	-23.71%
Total Long-Term Assets	$6.223M	$18.52M	$82.10M
YoY Change	-66.4%	-77.45%	-23.49%
TOTAL ASSETS
Total Short-Term Assets	$143.6M	$180.0M	$121.3M
Total Long-Term Assets	$6.223M	$18.52M	$82.10M
Total Assets	$149.8M	$198.6M	$203.4M
YoY Change	-24.54%	-2.4%	40.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.278M	$3.054M	$1.700M
YoY Change	-58.15%	80.87%	30.77%
Accrued Expenses	$8.286M	$8.637M	$5.500M
YoY Change	-4.07%	-10.49%	30.95%
Deferred Revenue	$3.281M	$2.298M
YoY Change	42.75%
Short-Term Debt	$0.00	$80.04M	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$0.00	$80.00M
YoY Change	-100.0%
Total Short-Term Liabilities	$10.48M	$91.74M	$11.30M
YoY Change	-88.57%	709.14%	66.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$75.50M
YoY Change		-100.0%	6.19%
Other Long-Term Liabilities	$9.600M	$9.000M	$13.60M
YoY Change	6.67%	-33.82%	-96.51%
Total Long-Term Liabilities	$9.600M	$9.000M	$89.10M
YoY Change	6.67%	-89.9%	-80.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.48M	$91.74M	$11.30M
Total Long-Term Liabilities	$9.600M	$9.000M	$89.10M
Total Liabilities	$20.04M	$100.8M	$100.5M
YoY Change	-80.12%	0.25%	-78.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$95.19M	-$123.0M
YoY Change	-22.63%	6.25%
Common Stock	$225.0M	$220.8M
YoY Change	1.89%	0.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$129.8M	$97.78M	$102.9M
YoY Change
Total Liabilities & Shareholders Equity	$149.8M	$198.6M	$203.4M
YoY Change	-24.54%	-2.4%	40.57%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2018
OPERATING ACTIVITIES
Net Income	$20.20M	-$4.503M	$421.8M
YoY Change	-548.59%	-108.59%	-1264.07%
Depreciation, Depletion And Amortization	$130.0K	$130.0K	$69.63K
YoY Change	0.0%	550.0%	-47.33%
Cash From Operating Activities	$45.95M	-$14.26M	$68.87M
YoY Change	-422.23%	297.21%	-474.57%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$102.3K
YoY Change		-100.0%	2.14%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$78.34M
YoY Change		-100.0%
Cash From Investing Activities	$0.00	$0.00	$78.24M
YoY Change		-100.0%	-78239.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net			$0.00
YoY Change
Cash From Financing Activities	-6.720M	-980.0K	-$3.813M
YoY Change	585.71%	-58.3%	551.09%
NET CHANGE
Cash From Operating Activities	45.95M	-14.26M	$68.87M
Cash From Investing Activities	0.000	0.000	$78.24M
Cash From Financing Activities	-6.720M	-980.0K	-$3.813M
Net Change In Cash	39.23M	-15.24M	$143.3M
YoY Change	-357.41%	-121.07%	-851.32%
FREE CASH FLOW
Cash From Operating Activities	$45.95M	-$14.26M	$68.87M
Capital Expenditures	$0.00	$0.00	$102.3K
Free Cash Flow	$45.95M	-$14.26M	$68.77M
YoY Change	-422.23%	305.11%	-471.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	76748446
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77195704
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77195704
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81269868
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81269868
CY2019Q4	siga	Receivables Percentage ReceivablesPercentage	1	pure
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117890240	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65249072	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	95737862	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3340263	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4167996	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	20265519	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2112069	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9652855	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5234000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	14151002	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	143608091	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	180041785	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2103990	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2618303	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2544053	USD
CY2020Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2019Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	676923	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	856766	USD
CY2020Q4	us-gaap	Assets Assets	149831391	USD
CY2019Q4	us-gaap	Assets Assets	198566190	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1278217	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3054032	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9205293	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8636911	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	80044866	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10483510	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	91735809	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6639211	USD
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6116882	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	2915401	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	2929743	USD
CY2020Q4	us-gaap	Liabilities Liabilities	20038122	USD
CY2019Q4	us-gaap	Liabilities Liabilities	100782434	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	7720	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	8127	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	224978430	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	220808037	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95192881	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123032408	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	129793269	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	97783756	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	149831391	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	198566190	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	124959304	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26742085	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	477053782	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14797419	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1782838	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	95268974	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14003184	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13252136	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12879738	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10938930	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13303149	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13016183	USD
CY2020	siga	Patent Preparation Fees PatentPreparationFees	719141	USD
CY2019	siga	Patent Preparation Fees PatentPreparationFees	726105	USD
CY2018	siga	Patent Preparation Fees PatentPreparationFees	789489	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	40458674	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	29064228	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10178423	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	411639556	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17166581	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2937276	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10168272	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	56342010	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7241147	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	121954384	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	84500630	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-2322143	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	355099398	USD
CY2020	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	3525846	USD
CY2019	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-5091256	USD
CY2018	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	6922624	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4981461	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Interest Expense InterestExpense	3016817	USD
CY2019	us-gaap	Interest Expense InterestExpense	15769768	USD
CY2018	us-gaap	Interest Expense InterestExpense	15478203	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	532085	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2822232	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	78940985	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	73508591	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	421807828	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.71
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.28
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.18
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79259000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81031254
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79923295
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79437306
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82175023
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82708472
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-323138291	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	421807828	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	261879	USD
CY2018	siga	Stock Issued During Period Value Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueStockSettledAppreciationRightsExercised	0	USD
CY2018	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	6007847	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4074440	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2273177	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	102914687	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7241147	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2019	siga	Stock Issued During Period Value Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueStockSettledAppreciationRightsExercised	0	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2019	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1172801	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1176579	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2113994	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	97783756	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	129793269	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	56342010	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	28502946	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	3003517	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	184016	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1350948	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	56342010	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7241147	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	421807828	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	529814	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	526997	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	69630	USD
CY2020	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	3525846	USD
CY2019	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-5091256	USD
CY2018	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	6922624	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1350948	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	2113994	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	2273177	USD
CY2020	siga	Net Realization Of Deferred Revenue And Costs Due To Fda Approval NetRealizationOfDeferredRevenueAndCostsDueToFdaApproval	-0	USD
CY2019	siga	Net Realization Of Deferred Revenue And Costs Due To Fda Approval NetRealizationOfDeferredRevenueAndCostsDueToFdaApproval	-0	USD
CY2018	siga	Net Realization Of Deferred Revenue And Costs Due To Fda Approval NetRealizationOfDeferredRevenueAndCostsDueToFdaApproval	281950853	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11606949	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2417617	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9301422	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4981461	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	887132	USD
CY2019	us-gaap	Paid In Kind Interest PaidInKindInterest	4497271	USD
CY2018	us-gaap	Paid In Kind Interest PaidInKindInterest	4497273	USD
CY2020	siga	Gain On Sale Of Prv GainOnSaleOfPrv	-0	USD
CY2019	siga	Gain On Sale Of Prv GainOnSaleOfPrv	-0	USD
CY2018	siga	Gain On Sale Of Prv GainOnSaleOfPrv	78338826	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-827733	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2208863	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	49723	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8009992	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6744644	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-39	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-699102	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	714272	USD
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2579329	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2204381	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	936839	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2045191	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	982606	USD
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1861605	USD
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3475714	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71519228	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18204303	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	68871323	USD
CY2020	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	15501	USD
CY2019	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	29094	USD
CY2018	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	102264	USD
CY2020	siga	Net Proceeds From Sale Of Priority Review Voucher NetProceedsFromSaleOfPriorityReviewVoucher	0	USD
CY2019	siga	Net Proceeds From Sale Of Priority Review Voucher NetProceedsFromSaleOfPriorityReviewVoucher	0	USD
CY2018	siga	Net Proceeds From Sale Of Priority Review Voucher NetProceedsFromSaleOfPriorityReviewVoucher	78338826	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15501	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29094	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	78236562	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	261879	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	184016	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1176579	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4074440	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	28502946	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	85913459	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	-0	USD
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	-0	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-114600421	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1176579	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3812561	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-43096694	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19409976	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	143295324	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160986934	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180396910	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37101586	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117890240	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160986934	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180396910	USD
CY2020	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	3003517	USD
CY2019	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	1172801	USD
CY2018	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	6007847	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	97250	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	118500	USD
CY2018	us-gaap	Stock Issued1 StockIssued1	1681426	USD
CY2020	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	3718581	USD
CY2019	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	-1276129	USD
CY2018	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	251961	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Use of Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. The most significant estimates include the variables used in the calculation of fair value of warrants granted or issued by the Company, reported amounts of revenue, and the valuation of deferred tax assets. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Actual results could differ from these estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p>
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117890240	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65249072	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100652809	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19857833	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	95737862	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11452078	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10701305	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	USD
CY2019Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	USD
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	68292023	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6542448	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117890240	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160986934	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180396910	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37101586	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Concentration of Credit Risk</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company has cash in bank accounts that exceeds the Federal Deposit Insurance Corporation insured limits. The Company has <em style="font: inherit;">not</em> experienced any losses on its cash accounts and <em style="font: inherit;">no</em> allowance has been provided for potential credit losses because management believes the potential for losses is remote.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p>
CY2020Q4	siga	Receivables Percentage ReceivablesPercentage	1	pure
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2020Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss Current ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent	1300000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	63500000	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2020	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6116882	USD
CY2020	siga	Increase Decrease In Fair Value Of Warrant Liability IncreaseDecreaseInFairValueOfWarrantLiability	3525846	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3003517	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6639211	USD
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2018Q4	siga	Proceeds From Sale Of Priority Review Voucher ProceedsFromSaleOfPriorityReviewVoucher	80000000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2628153	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15415425	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8693457	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2221941	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	959398	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	20265519	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9652855	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2944932	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2944932	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6274944	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6344616	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4170954	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3726313	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2103990	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2618303	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	529814	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	526997	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	69630	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	643570	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3280947	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2298341	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2933738	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2966139	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	486158	USD
CY2020Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	405176	USD
CY2019Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	256402	USD
CY2020Q4	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	327606	USD
CY2019Q4	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	707685	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	251824	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	288707	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	150349	USD
CY2019Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	71541	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	977724	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	919555	USD
CY2019Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	7093	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9205293	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8636911	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	56342010	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7241147	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	421807828	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.71
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.28
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.18
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5091256	USD
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6922624	USD
CY2020	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	56342010	USD
CY2019	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-12332403	USD
CY2018	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	428730452	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79259000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81031254
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79923295
CY2020	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	178306
CY2019	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1143769
CY2018	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2785177
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79437306
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82175023
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82708472
CY2020Q4	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	620000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	USD
CY2020	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	4600000
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	28500000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1400000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2300000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5111667	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-663114	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-1326022	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	447965	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	143455	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	459172	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5559632	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-519659	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-866850	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	11375962	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2092585	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9256661	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	230987	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-325032	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-44761	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11606949	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2417617	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9301422	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17166581	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10168272	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2937276	USD
CY2020Q4	siga	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	520830	USD
CY2019Q4	siga	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	678993	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	663114	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1141705	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1338046	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4144952	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15936739	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1022135	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1047008	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1293842	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9353603	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	80930	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	113910	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	398165	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	451818	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	709480	USD
CY2019Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	719304	USD
CY2020Q4	siga	Deferred Tax Assets Interest Expense DeferredTaxAssetsInterestExpense	0	USD
CY2019Q4	siga	Deferred Tax Assets Interest Expense DeferredTaxAssetsInterestExpense	2617951	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3122817	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	14889731	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	199172	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	201930	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	81065	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	175581	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	298527	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	361218	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2544053	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	14151002	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-24873	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.005	pure
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.007	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008	pure
CY2020	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants	0.010	pure
CY2019	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants	0.105	pure
CY2018	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants	0.004	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.060	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.003	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.021	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.247	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.234	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.289	pure
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.025	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5649188	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5738964	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5738964	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	57601	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	89776	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	-0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5591587	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5649188	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5738964	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	5600000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	65000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	38000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	700000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453	pure
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	550904	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	368467	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	402078	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	404258	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	406994	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	575887	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2708588	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	359467	USD
CY2020Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	12500000	USD

Files In Submission

Name	View Source	Status
0001437749-21-005031-index-headers.html	Edgar Link	pending
0001437749-21-005031-index.html	Edgar Link	pending
0001437749-21-005031.txt	Edgar Link	pending
0001437749-21-005031-xbrl.zip	Edgar Link	pending
ex_225003.htm	Edgar Link	pending
ex_225004.htm	Edgar Link	pending
ex_225005.htm	Edgar Link	pending
ex_225006.htm	Edgar Link	pending
ex_225008.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
grapha.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20201231.xsd	Edgar Link	pending
siga-20201231_cal.xml	Edgar Link	unprocessable
siga-20201231_def.xml	Edgar Link	unprocessable
siga-20201231_lab.xml	Edgar Link	unprocessable
siga-20201231_pre.xml	Edgar Link	unprocessable
siga20201231_10k.htm	Edgar Link	pending
siga20201231_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2020 Q4 Form 10-K Financial Statement

#000143774921005031 Filed on March 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2020 Q4 Form 10-K Financial Statement

#000143774921005031 Filed on March 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga